JATT mastermind launches latest biotech-focused SPAC in $60M IPO - Fierce Biotech

More on JATT

• 2026-06-29Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases - BioSpace
• 2026-06-29JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal - TradingView
• 2026-05-29JATT II Acquisition Corp. 1Q 2026: Net income $(68,793), EPS $(0.05) — 10-Q Summary - TradingView
• 2026-04-20JATT II Acquisition (NASDAQ: JATT) completes $60M SPAC IPO raise - Stock Titan
• 2026-04-20JATT II Acquisition Corp Raises $60M for AI-Driven Biotech Hunt - BriefGlance
• 2026-04-17JATT II Acquisition Corp. (JATT) Prices $63.0M SPAC IPO
• 2026-04-16JATT II Acquisition prices $60M SPAC IPO on Nasdaq - Investing.com